Company News
-
May 16, 2023
bioMérieux Triples Footprint in Philadelphia with 32,000 sq. ft. State-Of-The-Art Predictive Diagnostics Innovation Center
bioMérieux, a world leader in in vitro diagnostics, has announced the lease signing of a new, 32,000 sq. ft. state-of-the-art molecular innovation center at the Navy Yard in Philadelphia.
-
April 20, 2023
bioMérieux and JMI Labs partner against antimicrobial resistance (AMR)
bioMérieux and JMI Laboratories (JMI) are announcing a six-year partnership to undertake collaborative projects evaluating the performance and increasing potential of rapid and innovative microbiology diagnostics as important tools in the battle against AMR. -
March 07, 2023
bioMérieux Introduces GENE-UP® PRO GENDER ID and GENE-UP® PRO HOP LATENT VIROID (HLVd) Solutions
bioMérieux, a world leader in in vitro diagnostics for 60 years, is pleased to announce the availability of GENE-UP® PRO GENDER ID and GENE-UP® PRO HOP LATENT VIROID (HLVd) quality control solutions.
-
February 21, 2023
bioMérieux launches a PCR kit for detection of the monkeypox virus
bioMérieux has developed a MONKEYPOX R-GENE® PCR kit. Available for research use only (RUO), this kit can easily be used by laboratories around the world. -
February 02, 2023
bioMérieux Introduces GENE-UP® ENVIROPRO™
bioMérieux, a world leader in in vitro diagnostics, announces the availability of GENE-UP® ENVIROPRO™, the only assay of its kind to simultaneously detect both Salmonella and Listeria from environmental swabbing, including PCR confirmation.
Follow us on Socials for more news!
